You are here: Industry Insights > COVID-19

News List

Spending boost ‘welcome’ but more funding needed, says NHS Confed chief exec pharmatimes
November 24, 2020
The NHS Confederation’s chief executive Danny Mortimer has welcomed the extra ￡3bn investment for the NHS announced by the government, adding that ‘additional funding’ is needed.
Sagent Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 americanpharmaceuticalreview
November 24, 2020
Sagent Pharmaceuticals, a Nichi-Iko Group Company, has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the treatment of COVID-19 in high-risk outpatients and has begun enrolling patients.
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track contractpharma
November 24, 2020
ARCA biopharma, Inc., a company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, received Fast Track designation from the FDA for AB201 as a potential treatment for COVID-19.
Regeneron's COVID-19 Antibody Cocktail Gets EUA contractpharma
November 24, 2020
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA? Viral MagBead Kit prnasia
November 23, 2020
Zymo Research announced that its Quick-DNA/RNA? Viral MagBead Kit was cleared for distribution to the European Union (EU) common market.
New Peer-Reviewed Study: MMR Vaccine Protection Against COVID-19 Studied by World Organization prnewswire
November 23, 2020
In "Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients" researchers provide further proof to the theory that the measles-mumps-rubella (MMR) vaccine provides protection against COVID-19.
FDA clears expanded access IND for APT’s PhageBank therapy for Covid-19-related bacterial infections pharmaceutical-business-review
November 23, 2020
Adaptive Phage Therapeutics (APT) announced clearance by the U.S. Food and Drug Administration (FDA) of the company’s Expanded Access IND for PhageBank treatment for pneumonia or bacteremia/septicemia due to Acinetobacter baumannii, Pseudomonas ...
Potential anti-COVID-19 nasal spray developed by researchers europeanpharmaceuticalreview
November 23, 2020
A new nasal spray with ingredients already approved for use in humans could be used to protect people against COVID-19.
Sosei Heptares’ COVID-19 programme advances promising molecules pharmatimes
November 23, 2020
Japanese pharma company Sosei Heptares has identified and advanced the ‘most promising’ molecules in its COVID-19 research and development programme.
ADVAITE CLIA Lab Receives Authorization to Offer COVID-19 SalivaDirect Test americanpharmaceuticalreview
November 23, 2020
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect? test.